Sinsin Pharmaceutical Co. Ltd (002800) — Cash Flow-to-Debt Ratio
Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of ₩4.70 Billion could theoretically repay 0% of its total liabilities (₩65.10 Billion) in one year. See Sinsin Pharmaceutical Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sinsin Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Also explore 002800 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sinsin Pharmaceutical Co. Ltd (2016–2024)
Year-by-year debt coverage analysis for Sinsin Pharmaceutical Co. Ltd. For market capitalisation and broader financial context, see how much is Sinsin Pharmaceutical Co. Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | ₩5.94 Billion | ₩63.61 Billion | ▲ +48.2% |
| 2023 | 0.06x | ₩3.93 Billion | ₩62.32 Billion | ▼ -29.0% |
| 2022 | 0.09x | ₩5.46 Billion | ₩61.52 Billion | ▲ +22636.2% |
| 2021 | 0.00x | ₩23.18 Million | ₩59.38 Billion | ▼ -98.7% |
| 2020 | 0.03x | ₩1.87 Billion | ₩61.94 Billion | ▲ +148.7% |
| 2019 | -0.06x | ₩-4.51 Billion | ₩72.87 Billion | ▼ -526.3% |
| 2018 | 0.01x | ₩774.24 Million | ₩53.38 Billion | ▼ -91.5% |
| 2017 | 0.17x | ₩4.57 Billion | ₩26.74 Billion | ▲ +110.2% |
| 2016 | 0.08x | ₩2.79 Billion | ₩34.38 Billion | — |